Tumor-specific cytotoxicity and apoptosis-inducing activity of berberines

Anticancer Research

Volumn 25, Issue 6 B, 2005, Pages 4053-4059

  Inoue, Kanako ^a,b   Kulsum, Umme ^a   Chowdhury, Shahead Ali ^a   Fujisawa, Sei Ichiro ^a   Ishihara, Mariko ^a   Yokoe, Ichiro ^b   Sakagami, Hiroshi ^a  

^a MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^b JOSAI UNIVERSITY   (Japan)

Author keywords

Bad; Bcl 2; Berberine; Caspase; DNA fragmentation; Tumor specificity

Indexed keywords

ACETONEBERBERINE; ANTINEOPLASTIC AGENT; BERBERINE DERIVATIVE; BERBERINE IODIDE; CASPASE 3; CASPASE 8; CASPASE 9; DNA FRAGMENT; PROTEIN BAD; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL STRAIN HL 60; CONTROLLED STUDY; COPTIS; DRUG CYTOTOXICITY; ENZYME ACTIVITY; FIBROBLAST; GINGIVA; HUMAN; HUMAN CELL; MOUTH CARCINOMA; PERIODONTAL LIGAMENT; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TOOTH PULP; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BERBERINE; CARCINOMA, SQUAMOUS CELL; CASPASES; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME ACTIVATION; FIBROBLASTS; HL-60 CELLS; HUMANS; MODELS, MOLECULAR; MOUTH NEOPLASMS;

EID: 27944448368     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Nishida S, Kikuichi S, Yoshioka S, Tsubaki M, Fujii Y, Matsuda H, Kubo M and Irimajiri K: Induction of apoptosis in HL-60 cells treated with medicinal herbs. Am J Chin Med 31: 551-562, 2003.
2. Kuo CL, Chou CC and Yung BY: Berberine complexes with DNA in the berberine-induced apoptosis in human leukemic HL-60 cells. Cancer Lett 93: 193-200, 1995.
3. Jantova S, Cipak L, Cernakova M and Kost'alova D: Effect of berberine on proliferation, cell cycle and apoptosis in HeLa and L1210 cells. J Pharm Pharmacol 55: 1143-1149, 2003.
4. Yang IW, Chou CC and Yung BY: Dose-dependent effects of berberine on cell cycle pause and apoptosis in Balb/c 3T3 cells. Naunyn Schemiedebergs Arch Pharmacol 354: 102-108, 1996.
5. Hwang JM, Wang CJ, Chou FP, Tseng TH, Hsieh YS, Lin WL and Chu CY: Inhibitory effect of berberine on tert-butyl hydroperoxide-induced oxidative damage in rat liver. Arch Toxicol 76: 664-670, 2002.
6. Zheng L, Zhou Z, Tao D and Lan T: Protective effect of berberine on cardiac myocyte injured by ischemia-reperfusion. (in Chinese) Sichuan Da Xue Bao Yi Xue Ban 34: 452-454, 2003.
7. Lin HL, Liu TY, Wu CW and Chi CW: Berberine modulates expression of mdr1 gene product and the responses of digestive tract cancer cells to Paclitaxel. Br J Cancer 81: 416-422, 1999.
8. Miura N, Yamamoto M, Ueki T, Kitani T, Fukuda K and Komatsu Y: Inhibition of thymocyte apoptosis by berberine. Biochem Pharmacol 55: 1315-1322, 1997.
9. Sakagami H, Chowdhury SA, Suzuki F, Hashimoto K, Hatano H, Takekawa H, Ishihara M, Kikuchi H, Nishikawa H, Taniguchi S, Ito H, Hatano T, Yoshida T, Fukai T, Shirataki Y, Kawase M, Watanabe K, Mimaki Y, Itoh K, Horiuchi A, Chai W, Horiuchi A and Motohashi N: Tumor-specific cytotoxic activity of polyphenols, terpenoids, ketones and other synthetic compounds. In: Functional Polyphenols with Antioxidative Action, a review book series of "Chem. Pharmaceutical Sciences (CPS), Motohashi N (ed.), "REFLASH", India, pp. 133-176, 2005.
10. Onda M, Yuasa K, Okada J, Kataoka K and Abe K: Utilization of protopine and related alkaloids. VI. Chem Pharm Bull 21: 1333-1337, 1973.
11. Heyflick L: The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 37: 614-636, 1965.
12. Satoh R, Kishino K, Morshed SRM, Takayama F, Otsuki S, Suzuki F, Hashimoto K, Kikuchi H, Nishikawa H, Yasui T and Sakagami H: Changes in fluoride sensitivity during in vitro senescence of human normal oral cells. Anticancer Res 25: 2085-2090, 2005.
13. Chowdhury SA, Kishino K, Satoh R, Hashimoto K, Kikuchi H, Nishikawa H, Shirataki Y and Sakagami H: Tumor-specificity and apoptosis-inducing activity of stilbenes and flavonoids. Anticancer Res 25: 2055-2064, 2005.
14. Sakagami H, Ishihara M, Hoshino Y, Ishikawa J, Mikami Y and Fukai T: Cytotoxicity of nocobactins NA-a, NA-b and their ferric complexes assessed by semiempirical molecular orbital methods. In Vivo 19: 277-282, 2005.
15. Fujisawa S, Atsumi T, Satoh K, Kadoma Y, Ishihara M, Okada N, Kashiwagi Y, Yokoe I and Sakagami H: Radical generation, radical-scavenging activity and cytotoxicity of eugenol-related compounds. In Vitro Mol Toxicol 13: 269-279, 2000.
16. 3 against human oral tumor cell lines. Anticancer Res 21: 2387-2392, 2001.
17. Tashiro M, Suzuki F, Shirataki Y, Yokote Y, Akahane K, Motohashi N, Ishihara M, Jiang Y and Sakagami H: Effects of prenylflavones from Sophora species on growth and activation of mouse macrophage-like cell lines. Anticancer Res 22: 53-58, 2002.
18. Won J, Kim DY, La M, Kim D, Meadows GG and Joe CO: Cleavage of 14-3-3 protein by caspase-3 facilitates Bad interaction with Bcl-x(L) during apoptosis. J Biol Chem 278: 19347-19351, 2003.
19. Watabe M and Nakaki T: Rotenone induces apoptosis via activation of Bad in human dopaminergic SH-SY5Y cells. J Pharmacol Exp Therap 311: 946-953, 2004.
20. Kuo CL, Chi CW and Liu TY: Modulation of apoptosis by berberine through inhibition of cyclooxygenase-2 and Mcl-1 expression in oral cancer cells. In Vivo 19: 247-252, 2005.
21. Wu HL, Hsu CY, Liu WH and Yung BY: Berberine-induced apoptosis of human leukemia HL-60 cells is associated with down-regulation of nucleophosmin/B23 and telomerase activity. Int J Cancer 81: 923-929, 1999.
22. Lin SS, Chung JG, Lin JP, Chuang JY, Chang WC, Wu JY and Tyan YS: Berberine inhibits arylamine N-acetyltransferase activity and gene expression in mouse leukemia L1210 cells. Phytomedicine 12: 351-358, 2005.